AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod zbecker Fri, 04/26/2024 - 11:33

Gilead writes $2.4B off Trodelvy as CEO underscores ‘time of focused execution’ aliu Fri, 04/26/2024 - 11:05

Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose kdunleavy Fri, 04/26/2024 - 10:21

GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit fkansteiner Fri, 04/26/2024 - 10:07

AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again kdunleavy Fri, 04/26/2024 - 07:42

'The Top Line': A look at pharma revenue rankings aellison Thu, 04/25/2024 - 11:36